An Information Portal to 112722 Biological Macromolecular Structures

ACR is found in 32 entries
  •   Chemical Component Summary   Hide
    Identifiers 4,6-dideoxy-4-{[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranosyl-(1->4)-alpha-D-glucopyranose
    Formula C25 H43 N O18
    Molecular Weight 645.61 g/mol
    Type saccharide
    Isomeric SMILES
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00284   (Different stereochemistry)
    Name Acarbose
    • approved
    • investigational
    Description An inhibitor of alpha glucosidase that retards the digestion and absorption of carbohydrates in the small intestine and hence reduces the increase in blood-glucose concentrations after a carbohydrate load. It is given orally to non-insulin dependent diabetes mellitus patients where diet modification or oral hypoglycemic agents do not control their condition. (From Martindale The Extra Pharmacopoeia, 31st ed)
    • Acarbosa
    • Acarbose
    • Acarbosum
    • Glucobay
    • Precose
    Brand names
    • Acarbose
    • Glucobay
    • Precose
    • Prandase
    Affected organism Humans and other mammals
    Indication For treatment and management of diabetes type II (used in combination therapy as a second or third line agent)
    Pharmacology Used to reduce blood gluose in patients with type 2 diabetes. Acarbose is a complex oligosaccharide that delays the digestion of ingested carbohydrates, thereby resulting in a smaller rise in blood glucose concentration following meals. Acarbose binds to and inhibits alpha amylase and alpha-gluocside hydrolases. In diabetic patients, this enzyme inhibition results in a delayed glucose absorption and a lowering of postprandial hyperglycemia.
    Mechanism of action Acarbose reversibly bind to pancreatic alpha-amylase and membrane-bound intestinal alpha-glucoside hydrolases. These enzymes inhibit hydrolysis of complex starches to oligosaccharides in the lumen of the small intestine and hydrolysis of oligosaccharides, trisaccharides, and disaccharides to glucose and other monosaccharides in the brush border of the small intestine.
    Route of administration oral
    ATC-Code A10BF01
    AHFS-Code 68:20.02
    CAS number 56180-94-0
    Name Sequence search Pharmacological action Actions
    Maltase-glucoamylase, intestinal   Search  yes inhibitor
    Lysosomal alpha-glucosidase   Search  yes inhibitor
    Sucrase-isomaltase, intestinal   Search  yes inhibitor
    Pancreatic alpha-amylase   Search  yes inhibitor
Ligand Image